Please assess the completion status of the following clinical trial:

Trial Title: Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Participants must have met all of the following criteria to be included in this study:~  1. Diagnosis of epilepsy~ 2. Initiated treatment with Fycompa at any time after 01 Jan 2014~ 3. Provided written informed consent by the participant or the participant's legally authorized representative signed for the use of medical records (if required by an Institutional Review Board \[IRB\] or Independent Ethics Committee \[IEC\], or by regulatory authorities).~Exclusion Criteria:~* Not applicable

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Fycompa (Type: None): Participants diagnosed with epilepsy and treated with Fycompa

Based on this trial design, predict the completion outcome and termination type (if applicable).